| Fonds | Firma | ISIN | Rating | 2010 | 2009 | 3Jahre | Risiko 3Jahre | Agio | Management Gebühr | Fund Size EUR |
| UniSector: GenTech A | Union Investment Luxembourg S.A. | LU0125232032 | 5 | 1,56 | 29,36 | -0,68 | 17,56 | 4,00 | 1,75 | 17.786.162,00 |
| Dexia Eqs L Biotechnology C Acc | Dexia Asset Management | LU0108459040 | 4 | 4,23 | 39,95 | 2,07 | 26,17 | 3,50 | 1,50 | 51.850.128,79 |
| Allianz RCM Biotechnologie A EUR | Allianz Global Investors KAG mbH | DE0008481862 | 4 | 1,28 | 4,01 | -2,49 | 17,93 | 6,00 | 2,00 | 234.486.564,00 |
| SEB Concept BioTech B | SEB Asset Management S.A. | LU0118405827 | 4 | 1,94 | 11,62 | -3,25 | 20,41 | 5,00 | 1,00 | 47.543.768,00 |
| ESPA Stock Biotec A | ERSTE-SPARINVEST KAG | AT0000746748 | 4 | 2,37 | 16,87 | -3,56 | 16,97 | 4,00 | 2,16 | 30.530.424,00 |
| PF (LUX) Biotech P Cap | Pictet Funds (Europe) S.A. | LU0090689299 | 4 | 2,20 | -3,81 | -3,68 | 20,85 | 5,00 | 2,40 | 1.293.653.544,77 |
| UBS (LUX) EF Biotech B USD P | UBS Global Asset Management | LU0069152568 | 3 | 4,04 | 13,95 | 0,86 | 21,53 | 6,00 | 2,04 | 191.144.697,23 |
| FCP OP MEDICAL BioHe@lth-Trds EUR | Oppenheim Asset Mgmt Services S.à r.l. | LU0119891520 | 3 | 0,59 | 66,96 | -1,58 | 24,34 | 5,00 | 1,90 | 53.604.816,00 |
| Franklin Biotechnology Disc A Acc $ | Franklin Templeton Investment Funds | LU0109394709 | 3 | 4,18 | 7,40 | -3,07 | 18,61 | 6,50 | 1,00 | 44.491.458,23 |
| Clariden Leu (Lux) Biotechnology Eq B | Clariden Leu AG | LU0130190969 | 3 | 2,56 | 5,30 | -4,03 | 20,80 | 5,00 | 2,00 | 96.242.771,97 |
| DekaLux-BioTech CF | Deka International S.A. | LU0348461467 | 3 | 2,19 | 13,82 | -5,52 | 21,03 | 3,75 | 2,00 | 109.275.030,00 |
| Nordea-1 Biotech BP | Nordea-1 SICAV | LU0109905058 | 3 | 1,13 | 7,84 | -6,21 | 17,89 | 5,00 | 1,50 | 26.755.621,38 |
| Fortis L Equity Biotech World Acc | Fortis Investments (BE) | LU0086351706 | 3 | 3,31 | 3,85 | -7,54 | 20,78 | 5,00 | 1,50 | 71.327.981,00 |
| KBC Equity Biotechnology Acc | KBC Asset Management N.V. | BE0164856537 | 3 | 1,74 | 11,55 | -8,82 | 18,97 | 3,00 | 1,35 | 18.044.824,37 |
| ING (L) Invest Biotechnology P USD Acc | ING Investment Mgmt Luxembourg | LU0119199106 | 3 | 3,28 | 5,69 | -9,94 | 16,28 | 3,00 | 1,50 | 51.448.012,66 |
| DWS Biotech-Aktien Typ O | DWS Investment GmbH | DE0009769976 | 2 | 3,41 | 9,00 | -3,67 | 22,07 | 1,70 | 174.552.506,00 | |
| CS EF (Lux) Global Biotech Aberdeen B | Credit Suisse | LU0111979901 | 2 | 3,87 | 3,17 | -5,79 | 18,89 | 5,00 | 1,92 | 26.214.696,38 |
| SL (Lux) Equity Biomedical R Acc | Swiss Life Funds AG | LU0126497543 | 2 | 2,90 | 23,03 | -7,27 | 22,11 | 5,00 | 1,50 | 26.877.011,00 |
| Lacuna - APO BioTech | IP Concept Fund Management S.A. | LU0095994793 | 2 | 2,65 | 11,78 | -15,39 | 22,99 | 5,00 | 0,09 | 24.772.379,00 |
| Oyster Oncology USD | Oyster Asset Management S.A. | LU0096450472 | 1 | 2,32 | 3,58 | -8,25 | 18,44 | 5,00 | 1,75 | 13.101.903,02 |
| Bellevue Fds (LUX) BB Biotech B | Bellevue Asset Management AG | LU0415392322 | 3,39 | 5,00 | 1,60 | 29.628.488,40 | ||||
| JB EF Biotech A CHF | Swiss & Global Asset Management AG | LU0329426364 | 2,90 | 1,01 | 1,60 | 8.051.026,87 | ||||
| Kategoriedurchschnitt Branchenfonds Biotechnologie | 3 | 2,39 | 12,03 | -4,15 | 17,79 | 696.990.000,00 | ||||
| MSCI World/Biotechnology NR USD | Morgan Stanley Capital Intl (MSCI) | 3,06 | -2,09 | -0,93 | 19,27 | 133.285.072.384,10 | ||||
| MSCI World NR USD | Morgan Stanley Capital Intl (MSCI) | -0,08 | 25,94 | -9,03 | 17,92 | 15.142.715.768.106,40 | ||||
| MSCI Europe NR USD | Morgan Stanley Capital Intl (MSCI) | -1,90 | 31,60 | -9,86 | 20,38 | 4.761.912.416.276,63 | ||||
| MSCI USA NR USD | Morgan Stanley Capital Intl (MSCI) | 0,17 | 22,32 | -9,37 | 17,78 | 7.295.950.215.000,40 | ||||
| MSCI Germany NR USD | Morgan Stanley Capital Intl (MSCI) | -4,61 | 21,26 | -7,50 | 24,14 | 575.754.787.666,19 | ||||
| Stand: 27.1.2010 | ||||||||||